K.Yogendra*, S. Rajini, V.Mohana, G.V.Chari, P.Supraja, M.Prasada Rao
M.A.M College of Pharmacy, Narsaraopeta, Guntur District, A.P.
Introduction: Quality of Life assessment has become increasingly common in the field of cancer and has been identified as the second most important outcome with survival being the most important. For patients and their family, a diagnosis of cancer brings challenges to many aspects of daily life, with a major concern being maintaining the highest quality of life possible during and after the experience. This study was carried out with the objective of measuring the quality of life of pediatric leukemic patients during their cancer treatment. Materials and Methodology: The data required for the study was collected from the patients at Primary Healthcare Hospital. The data is collected from Leukemic pediatric patients who were in the Oncology department. The Quality of Life was measured by using PedsQL, A prominent Quality assessing scale for pediatrics. The data was computed from the patient data collection forms. Data pertaining to physical functioning, emotional functioning, social functioning, school functioning characteristics of patients was stockpiled. Results: Physical Functioning ( P > 0.05), Emotional Functioning ( P > 0.05), Social Functioning ( P > 0.05), School functioning ( P > 0.05). The significance (2 tailed) values Emotional Functioning implicate that most of the patients have angry. The significance (2 tailed) values Social Functioning implicate that most of the patients getting teased by other children. The significance (2 tailed) values School Functioning implicate that most of the patients have problems with paying attention in classs, keeping up with school work, missing school because of not feeling well, missing school to go to doctor or hospital. Conclusion: Anxiety, irritability, worries, depression, and aggression were also sometimes a barrier to communicate with the patients and for them to complete the questionnaire. It should be noted that the approximate time to enter the study for this number of subjects (n = 49) was 3 months. Another limitation was the limited environment of the study; due to this limitation, studying patients with leukemia admitted in other hospitals at the same time was not possible. Based on the limitations of this study, including the small number of subjects, applying the study only in one hospital, and in only one section, and the problems of generalizability, it is recommended for further similar studies to be conducted in other hospitals with larger sample size.